- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/15 - DepsipeptidesDerivatives thereof
Patent holdings for IPC class A61K 38/15
Total number of patents in this class: 345
10-year publication summary
|
26
|
28
|
31
|
30
|
28
|
24
|
21
|
25
|
27
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pharma Mar, S.A. | 214 |
26 |
| Celgene Corporation | 1387 |
17 |
| Bayer Animal Health GmbH | 202 |
11 |
| Onkure, Inc. | 30 |
9 |
| Boehringer Ingelheim Animal Health USA Inc. | 419 |
9 |
| St. Jude Children's Research Hospital | 239 |
8 |
| University of Florida Research Foundation, Inc. | 4140 |
7 |
| NovoBiotic Pharmaceuticals, LLC | 23 |
7 |
| Zoetis Services LLC | 1538 |
7 |
| The Trustees of Columbia University in the City of New York | 3616 |
6 |
| Trustees of Boston University | 977 |
6 |
| Viracta Subsidiary, Inc | 17 |
6 |
| Celgene Quanticel Research, Inc. | 156 |
5 |
| Fleurir ABX LLC | 12 |
5 |
| Animol Discovery, Inc. | 9 |
5 |
| Chung-Ang University Industry-Academy Cooperation Foundation | 467 |
4 |
| Desert King International, LLC | 37 |
4 |
| The Kitasato Institute | 156 |
4 |
| Reapplix ApS | 20 |
4 |
| The Regents of the University of Colorado, a body corporate | 2767 |
4 |
| Other owners | 191 |